Kieron White

39 posts

Kieron White banner
Kieron White

Kieron White

@_KieronWhite

Postdoctoral researcher at Subklewe Lab - Translational Cancer Immunology | Bioinformatician

Munich, Bavaria Katılım Şubat 2023
151 Takip Edilen54 Takipçiler
Sabitlenmiş Tweet
Kieron White
Kieron White@_KieronWhite·
Dr. White!!😅 Delighted to be awarded my PhD after 4 years of hard work, filled with incredible memories and limited sleep! A huge thankyou to everyone who helped me get to this stage! A special thanks to my supervisor @NetByrne and Dr. Kate Connor for their endless support
Kieron White tweet media
English
5
1
41
1.9K
Kieron White
Kieron White@_KieronWhite·
Our e-poster (EXTH-64) is still available to view incase you missed us at the poster presentation!
English
0
1
1
187
Kieron White
Kieron White@_KieronWhite·
Just back from #SNO2023 in beautiful Vancouver. Great conference with insightful discussions surrounding the importance of accurate GBM models for assessment of novel therapies. Very grateful for the funding bodies and collaborations for making this work possible
Kieron White tweet mediaKieron White tweet mediaKieron White tweet media
English
1
2
6
1.5K
Kieron White retweetledi
Roel Verhaak
Roel Verhaak@roelverhaak·
And another potential oncolytic virus response win for glioblastoma! Clinical trial links oncolytic immunoactivation to survival in glioblastoma nature.com/articles/s4158…
English
0
22
87
9.1K
Kieron White retweetledi
Eric Topol
Eric Topol@EricTopol·
If you're interested in how our immune system and immune-directed interventions interact with cancer, you'd be hard pressed to find a better, up-to-date review than this one cell.com/immunity/fullt… @ImmunityCP @TurleyLabGNE . .
Eric Topol tweet mediaEric Topol tweet mediaEric Topol tweet mediaEric Topol tweet media
English
2
258
871
123.8K
Kieron White retweetledi
RAMI
RAMI@RAMIreland·
RAMI Research Awards, 25th Sept 2023, short-listed entries and winners. Congrats to all rami.ie/event/rami-res…
English
0
1
2
537
Kieron White
Kieron White@_KieronWhite·
Great opportunity to discuss our data at the #CICON23 conference. Establishing a clinically relevant GBM model is critical to understand treatment response + ultimately translate novel TME targeting agents to the clinic
Kieron White tweet media
Milan, Lombardy 🇮🇹 English
0
2
10
1.1K
Kieron White
Kieron White@_KieronWhite·
Excellent talk from @sautesfridm explaining the role of TLS and B cells in immunotherapy response at the #CICON conference in Milan. Exciting to see our recent TLS findings in GBM included!
Kieron White tweet media
English
0
1
4
250
Kieron White retweetledi
GLIORESOLVE
GLIORESOLVE@Glioresolve·
Great 1st Plenary meeting for the GLIORESOLVE network today. Welcoming our new students, catching up with some familiar faces and meeting some people in person for the first time 🙏 Looking forward to the next 3.5 years! @NetByrne @MSCActions @HorizonEU @HorizonEuropeIE
GLIORESOLVE tweet media
English
0
6
16
1.6K
Kieron White retweetledi
Dana-Farber News
Dana-Farber News@DanaFarberNews·
“Seeing these patients do well on the trial has been really gratifying," said Patrick Wen, director of the center for neuro-oncology @DanaFarber. Read more in @WSJ about this treatment breakthrough for an intractable brain cancer, presented at #ASCO23: wsj.com/articles/treat…
English
0
5
12
2.3K
Kieron White retweetledi
NEJM
NEJM@NEJM·
Late breaking at #ASCO23: Mutations in isocitrate dehydrogenase 1 or 2 are common in low-grade glioma. The IDH inhibitor vorasidenib improved progression-free survival as compared with placebo. Full results of the INDIGO trial: nej.md/3N8N5dU
English
6
209
463
325.6K
Kieron White retweetledi
RCSI
RCSI@RCSI_Irl·
Today's @IrishTimes features a magazine dedicated to the pioneering work of the Beaumont RCSI @CancerCentreIre.
 
Read how the Centre is leading the fight against cancer with patient-partnered care informed by research.
 
Pick up a copy or read online: bit.ly/Cancercentre
RCSI tweet media
English
1
20
63
22.4K
Kieron White
Kieron White@_KieronWhite·
Very exciting to see our TME subtypes being applied to assess the outcome of oncolytic virus therapy in GBM. Interesting to see TME-Med appears to be associated with improved response to DNX-2401 + anti-PD1 treatment
Nature Medicine@NatureMedicine

A phase 1 trial of the #OncolyticVirus DNX-2401 followed by intravenous anti-PD-1 #Pembrolizumab in patients w/recurrent #Glioblastoma shows an encouraging clinical benefit rate & 12 months overall survival. nature.com/articles/s4159… @gelarehzadeh @FarshadNassiri

English
0
1
1
219
Kieron White
Kieron White@_KieronWhite·
Final version of my thesis submitted, roll on graduation!🎓
Kieron White tweet mediaKieron White tweet media
English
0
0
16
550
Kieron White
Kieron White@_KieronWhite·
A huge thankyou to the collaborators and funding bodies involved in this project and @EACRnews for the opportunity to present this work
English
0
0
1
86
Kieron White
Kieron White@_KieronWhite·
Great opportunity presenting our poster where we have established a clinically relevant model of Mes GBM. Using subtype-specific models which more accurately mirror treatment response (+ TME) in patients will likely guide more effective therapeutic strategies #eacrImmunoOncology
Kieron White tweet media
English
1
2
11
1.3K
Kieron White
Kieron White@_KieronWhite·
Super thought-provoking first day at the immuno-oncology breakthroughs conference, located at the stunning la pedrera. Loaded up on tapas ready for day 2! #eacrImmunoOncology
Kieron White tweet media
English
0
5
12
1.9K